Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07582978

Impact of the Procurement Technique on Outcomes After Liver Transplantation

Liver transplantation (LT) is the standard treatment for hepatocellular carcinoma (HCC) and end-stage liver disease, with excellent long-term outcomes despite the increasing use of extended criteria donors due to organ shortage. As traditional evaluation criteria have become insufficient, new indicators such as Arterial and Biliary Complication-Free Survival (ABCFS) have been developed to better assess post-transplant outcomes.

Primary objective: To assess, in a large-scale study, whether the procurement technique influences liver transplantation outcomes in terms of arterial and biliary complication-free survival.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 years or older at the time of inclusion
  • Listed on the national waiting list of the Agence de la Biomédecine (ABM)
  • Undergoing a first liver transplantation in France
  • Receiving a whole liver graft
  • No prior or subsequent transplantation of another organ

Exclusion criteria

  • Pancreas procurement
  • Multiorgan transplantation
  • Split liver transplantation (shared grafts)
  • Retransplantation
  • Domino transplantation (no actual organ procurement in the conventional sense)
  • Patient refusal to allow the use of their data

Treatment and study plan

Primary outcomes

  1. Arterial and Biliary Complication-Free Survival (ABCFS) at 3 years

    Time frame: at 3 years post-transplantation

Secondary outcomes

  1. Postoperative complications at 90 days

    Time frame: at 90 days post-transplantation

  2. Type of Biliary complications

    Time frame: Up to 3 years post-transplantation

  3. Type of Arterial complications

    Time frame: Up to 3 years post-transplantation

  4. Occurrence of vascular injuries observed following organ procurement

    Time frame: Peri-procedural period (during procurement and immediately post-procurement)

  5. Rehospitalization Rate Post-LT

    Time frame: Up to 3 years post-transplantation

    Number of rehospitalizations per patient occurring after the initial transplantation hospitalization.

  6. Duration of Rehospitalizations Post-LT

    Time frame: Up to 3 years post-transplantation

    Length of stay for each rehospitalization occurring after the initial transplantation hospitalization.

  7. Reasons for Rehospitalizations Post-LT

    Time frame: Up to 3 years post-transplantation

    Reason for each rehospitalization occurring after the initial transplantation hospitalization, categorized by diagnosis.

Study contacts

Contact information is provided by the study sponsor or research team.

Eric Savier, MD, PhD

CONTACT

[email protected]

+33 1 42 17 56 90

Jinmi BAEK

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Impact of the Procurement Technique on Outcomes After Liver Transplantation: a French Multicenter Prospective Study

Acronym: PLVT_TH

Important dates

Study start
2026
Primary completion
2031
Study completion
2031
First posted
May 13, 2026
Registry last updated
May 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.